Skip to main content
. 2017 Apr 21;13(6):4641–4650. doi: 10.3892/ol.2017.6065

Table II.

Gender distribution for the Philadelphia-negative myeloproliferative neoplasm cases (n=133).

Diagnosis Patients, n Male, n (%) Female, n (%)
ET 80 32 (40.0) 48 (60.0)
PV 39 20 (51.3) 19 (48.7)
PMF 14 9 (64.3) 5 (35.7)

ET, essential thrombocythaemia; PV, polycythaemia vera; PMF, primary myelofibrosis.